The prognostic advantage of preoperative intratumoral injection of OK-432 for gastric cancer patients

British Journal of Cancer

Volumn 84, Issue 4, 2001, Pages 443-451

  Gochi, A ^a   Orita, K ^a   Fuchimoto, S ^a   Tanaka, N ^a   Ogawa, N ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Intratumoral injection; Medical lymphadenectomy; OK 432 (picibanil); Preoperative immunotherapy

Indexed keywords

MITOMYCIN C; PICIBANIL; TEGAFUR;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; STOMACH CANCER;

ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; PICIBANIL; PROGNOSIS; STOMACH NEOPLASMS;

EID: 0035099833     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1599     Document Type: Article

References (43)

1. The effects of intratumoral OK-432 injection in gastric cancer patients
2. A trial of adjuvant chemoimmunotherapy with mitomycin C and OK-432 for stage III gastric carcinoma
3. Structural representations of tumor-host relationships in gastric carcinoma
4. Immunotherapy using the streptococcal preparation OK-432 for the treatment of uterine cervical cancer
5. Immunosensitization of prostate carcinoma cell lines for lymphocytes (CTL, TIL, LAF)-mediated apoptosis via the Fas-Fas-ligand pathway of cytotoxicity
6. Augmentation of cytotoxicity of tumor infiltrating lymphocytes by biological response modifiers
7. 5-Fluoropyrimidines
8. The decline in gastric cancer: Epidemiology of an unplanned triumph
9. Augmentation of interleukin 1 and interleukin 2 production by OK-432
10. Clonal dominance of human autologous cytotoxic T lymphocytes against gastric carcinoma: Molecular stability of CDR3 structure of T cell receptor αβ gene
11. Postoperative adjuvant chemotherapy of gastric carcinoma. Analysis of data on 1805 patients followed for 5 years
12. Cytotoxic T cells from ovarian malignant tumors can recognize polymorphic epithelial mucin core peptides
13. Inhibition of tumor growth in vivo and in vitro by macrophages from rats treated with a streptococcal preparation, OK-432
14. Interleukin-2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanoma
15. Fas and perforin pathway as major mechanisms of T-cell mediated cytotoxicity
16. In vitro induction of perforin mRNA and cytotoxic activities in human splenocytes by streptococcal preparation, OK-432
17. The oligoclonality and ctyokine secretion in TIL and PBMC of patients with ovarian cancer
18. Perforin: Structure and function
19. Repression of IL-2 mRNA translation in primary human breast cancer tumor-infiltrating lymphocytes
20. Cytolytic T-cell ghjjkcytotoxicity in mediated through perforin and Fas lytic pathways
21. Relation of differentiation and lymphocytic infiltration to postoperation longevity in gastric carcinoma
22. Adjuvant chemotherapy enhances long-term survival of patients with advanced gastric cancer following curative resection
23. Neutralizing anti-IL-10 antibody upregulates the induction and elicitation of contact hypersensitivity
24. Increase in T cell infiltration in carcinoma tissue and regional lymph node reaction to gastric cancer after local injection of immunomodulators before gastrectomy
25. Intratumoral administration of immune modulator PSK (Krestin) and its effect on lymphocyte population present in tumor and peripheral blood
26. Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer
27. Levamisole in postoperative adjuvant immunochemotherapy for gastric cancer. A randomized controlled study of the MMC + tegafur regimen with or without levamisole report 1
28. Prognostic significance and surgical management of lymph node metastasis in gastric cancer
29. Induction of IFN-γ in mouse spleen cell by OK-432, a preparation of streptococcus pyogenes
30. Therapy for oral squamous cell carcinoma by tegafur and streptococcal agent OK-432 in combination with radiotherapy: Association of the therapeutic effect with differentiation and apoptosis in cancer cells
31. Tumor-specific lysis of human renal cell carcinomas by tumor infiltrating lymphocytes
32. Prognostic relevance of systemic lymph node dissection in gastric carcinoma
33. Cellular immune response to human sarcoma; cytotoxic T cell clone reactive with autologous sarcomas
34. Stomach cancer mortality trends in U.S. men and women
35. Intratumoral injection of a streptococcal preparation. OK-432, before surgery for gastric cancer. A Randomized Trial
36. Gastric cancer registry in Japan - 5 year survival rate of cases between 1963 and 1966
37. The cytocidal activity of OK-432-activated mononuclear cells against human glioma cells is partly mediated through the Fas ligand/Fas system
38. Tumor-specific cytolysis by lymphocytes infiltrating human melanomas
39. Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and pleural effusion lymphocytes activated by OK-432
40. Clinical value of immunotherapy for lung cancer by the streptococcal preparation OK-432
41. Release of tumor necrosis factor (TNF) into mouse peritoneal fluids by OK-432, a streptococcal preparation
42. Effect of picibanil (OK-432) on neutrophil-mediated antitumor activity: Implication of monocyte-derived neutrophil-activating factors
43. HLA restriction and T-cell-receptor V6 gene expression of cytotoxic T lymphocytes reactive with human squamous cell carcinoma of the head and neck